The observation abnormal nuclear and cytoplasmic TDP-43 aggregation can correlate with disease progression in ALS and FTLD indicates that if this accumulation can be inhibited the resulting phenotypic changes may be alleviated magnifying the importance of understanding the mechanisms leading to these TDP-43 lesions [15], [23]. Here, TARDBP is linked to amyotrophic lateral sclerosis.